- Info
- Significant Ownership
- Insider Trading
- Financials
- Holders: AZN, AZN
Significant Ownership of ASTRAZENECA PLC
- Signature - Title
- /s/ Matthew Bowden - Matthew Bowden / Company Secretary
- Location
- Cambridge
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by ASTRAZENECA PLC.
Follow Filing Activity
Follow ASTRAZENECA PLC and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of ASTRAZENECA PLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CLLS | Cellectis S.A. | Ordinary shares, nominal value of EUR0.05 per ordinary share | 44% | $66,440,000 | 44,000,000 | AstraZeneca PLC | 23 Jan 2025 | ||
| Innate Pharma SA | Ordinary Shares, EUR0.05 nominal value per share | 8.3% | 7,825,501 | AstraZeneca PLC | 22 Dec 2025 | ||||
| MNPR | Monopar Therapeutics Inc. | Common Stock, $0.001 par value per share | 7.8% | $34,126,392 | 522,667 | AstraZeneca PLC | 31 Dec 2025 | ||
| CDT | Conduit Pharmaceuticals Inc. | Common Stock, par value $0.0001 per share | 1.1% | $3,340 | 73,892 | AstraZeneca PLC | 31 Mar 2025 |
Schedules 13D/G Reported by ASTRAZENECA PLC:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.